United States · Markets & Finance · Quartz

Roche struck a cancer drug licensing deal with China's Hansoh that could exceed $15 billion

Published by Quartz · United States 1 h ago

Hansoh will receive $400 million upfront and keep rights to the programs in mainland China, Hong Kong, Macau and Taiwan

Read the full article on Quartz Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (qz.com)

Also worth reading

Women may be at greater risk of AI job losses. Telephone switch operators and PCs show why

Business Insider

AI could eat Big Law's billable hours. Cooley's boss says bring it on.

How Boston Dynamics is turning robots into a real business

Strategy Buys $22M in Bitcoin, Buys Back $193M of STRC

Apple updates guidelines to ban nudify apps masquerading as regular apps to pass review

Elon Musk Says He Will Give a SpaceX Share to ‘Every Kid in America’